다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Corautus Genetics (MM) (VEGF)
Corautus Genetics (MM) (VEGF) 뉴스

VEGF

Corautus Genetics (VEGF)

Corautus Genetics (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VEGF

일자	시간	출처	헤드라인	심볼	기업
2007/06/05	08:04	PR Newswire (US)	Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals	NASDAQ:VEGF	Corautus Genetics (MM)
2007/05/30	05:00	PR Newswire (US)	Corautus Genetics Receives Nasdaq Additional Deficiency Notice	NASDAQ:VEGF	Corautus Genetics (MM)
2007/02/08	22:00	PR Newswire (US)	Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement	NASDAQ:VEGF	Corautus Genetics (MM)
2007/01/18	02:30	PR Newswire (US)	Corautus Announces Discussions	NASDAQ:VEGF	Corautus Genetics (MM)
2006/12/15	06:00	PR Newswire (US)	Corautus Genetics Inc. Receives Determination Letter from Nasdaq Regarding Continued Listing	NASDAQ:VEGF	Corautus Genetics (MM)
2006/11/14	22:00	PR Newswire (US)	Corautus Genetics Reports Third Quarter Financial Results	NASDAQ:VEGF	Corautus Genetics (MM)
2006/11/08	05:00	PR Newswire (US)	Corautus Genetics Inc. to Host Conference Call on November 14, 2006	NASDAQ:VEGF	Corautus Genetics (MM)
2006/11/04	06:10	PR Newswire (US)	Corautus Genetics Announces Redirection of Focus and Transition Of Officers	NASDAQ:VEGF	Corautus Genetics (MM)
2006/10/10	22:00	PR Newswire (US)	Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial	NASDAQ:VEGF	Corautus Genetics (MM)
2006/08/10	21:58	PR Newswire (US)	Corautus Genetics Reports Second Quarter Financial Results	NASDAQ:VEGF	Corautus Genetics (MM)
2006/08/08	22:00	PR Newswire (US)	Corautus Genetics Inc. to Host Conference Call on August 10, 2006	NASDAQ:VEGF	Corautus Genetics (MM)
2006/07/13	21:58	PR Newswire (US)	Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock	NASDAQ:VEGF	Corautus Genetics (MM)
2006/07/06	22:00	PR Newswire (US)	Corautus Genetics Announces Conversion of Boston Scientific Debt Into Equity	NASDAQ:VEGF	Corautus Genetics (MM)
2006/06/20	22:15	PR Newswire (US)	Corautus Genetics to Present at Jefferies Life Sciences Conference	NASDAQ:VEGF	Corautus Genetics (MM)
2006/05/31	21:58	PR Newswire (US)	Corautus Genetics Announces Filing of Response to FDA Clinical Hold	NASDAQ:VEGF	Corautus Genetics (MM)
2006/05/27	02:00	PR Newswire (US)	Corautus Genetics Receives NASDAQ Deficiency Notice Related to Minimum Bid Price	NASDAQ:VEGF	Corautus Genetics (MM)
2006/05/15	22:00	PR Newswire (US)	Corautus Genetics Reports an Update of its Therapeutic Development Program and First Quarter Financial Results	NASDAQ:VEGF	Corautus Genetics (MM)
2006/05/08	22:00	PR Newswire (US)	Corautus Genetics Inc. to Host Conference Call on May 15, 2006	NASDAQ:VEGF	Corautus Genetics (MM)
2006/04/19	22:00	PR Newswire (US)	Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical Operations	NASDAQ:VEGF	Corautus Genetics (MM)
2006/04/10	21:45	PR Newswire (US)	Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical Trial	NASDAQ:VEGF	Corautus Genetics (MM)
2006/04/04	23:00	PR Newswire (US)	Corautus Genetics Inc. to Present at BIO 2006 Business Forum	NASDAQ:VEGF	Corautus Genetics (MM)
2006/03/20	22:00	PR Newswire (US)	Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS Tria	NASDAQ:VEGF	Corautus Genetics (MM)
2006/03/14	22:31	PR Newswire (US)	Corautus Genetics Inc. Announces Developments in Clinical Trial and Public Offering	NASDAQ:VEGF	Corautus Genetics (MM)
2006/03/10	22:06	PR Newswire (US)	Corautus Genetics Inc. Announces Pricing of Equity Offering	NASDAQ:VEGF	Corautus Genetics (MM)
2006/02/25	06:42	PR Newswire (US)	Corautus Genetics Announces Proposed Public Offering of Common Stock	NASDAQ:VEGF	Corautus Genetics (MM)
2006/02/23	22:00	PR Newswire (US)	Corautus Genetics Announces Update on GENASIS Trial	NASDAQ:VEGF	Corautus Genetics (MM)
2006/01/26	22:00	PR Newswire (US)	Corautus Genetics' Phase IIb Clinical Trial for Severe Angina Treatment Receives Go-Ahead from Data Safety Monitoring Committee	NASDAQ:VEGF	Corautus Genetics (MM)
2006/01/11	22:00	PR Newswire (US)	Corautus Genetics Announces Collaboration for Phase I Trial for the Treatment of Critical Limb Ischemia with VEGF-2	NASDAQ:VEGF	Corautus Genetics (MM)
2005/11/10	22:00	PR Newswire (US)	Corautus Genetics Reports Third Quarter Results	NASDAQ:VEGF	Corautus Genetics (MM)
2005/11/03	22:02	PR Newswire (US)	Corautus Genetics Receives FDA Fast Track Designation for VEGF-2	NASDAQ:VEGF	Corautus Genetics (MM)

검색 관련기사 보기:NASDAQ:VEGF

Health Care Select Portf...

Otonomo Technologies

Vontobel Financial Produ...

Welsbach Technology Meta...

엑세스바이오

BBASH395 Ex:19,75

Societe Generale Effekten

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관